Related Experiment Videos
Endogenous lectins as targets for drug delivery
N Yamazaki1, S Kojima, N V Bovin
1Materials Design Laboratory, Department of Organic Materials, National Institute of Materials and Chemical Research, 1-1 Higashi, Tsukuba-City, 305, Ibaraki, Japan. n.yamazaki@home.nimc.go.jp
Advanced Drug Delivery Reviews
|September 1, 2000
Summary
Harnessing the "sugar code," researchers are developing custom neoglycoconjugates for targeted drug delivery. These carbohydrate-based molecules leverage cell surface lectins to precisely deliver therapeutics, minimizing side effects and enhancing treatment efficacy.
Area of Science:
- Carbohydrate Chemistry
- Biomaterials Science
- Drug Delivery Systems
Background:
- Minimizing drug side effects requires targeted delivery to specific cell types.
- Oligosaccharides (carbohydrate chains) offer vast information storage potential for cellular recognition.
- Cellular recognition systems, particularly carbohydrate-based ones, are key to developing targeted therapies.
Purpose of the Study:
- To explore the potential of the "sugar code" and neoglycoconjugates for targeted drug delivery.
- To design biomimetic strategies for precise therapeutic localization.
- To leverage endogenous lectin-carbohydrate interactions for drug targeting.
Main Methods:
- Conjugating custom glycan epitopes to proteins or polymeric scaffolds to create neoglycoconjugates.
- Investigating the interaction between neoglycoconjugates and endogenous cell lectins.
- Rational design of oligosaccharide ligands, considering functional groups, topology, clustering, and spacer characteristics.
- Studying specific examples like trivalent cluster glycosides for C-type asialoglycoprotein receptors.
Main Results:
- Neoglycoconjugates exhibit purpose-adaptable properties for drug delivery.
- Oligosaccharides, such as histo-blood group trisaccharides, have demonstrated practical applications in targeting.
- Optimized ligand design, including clustering and spacer characteristics, can achieve high-affinity binding (nM-affinity).
Conclusions:
- The "sugar code" and custom neoglycoconjugates hold significant potential for advanced drug delivery systems.
- Targeting tissue lectins with neoglycoconjugates offers a promising strategy for cell-specific therapeutic payload delivery.
- Further research into lectin-carbohydrate interactions can lead to novel cell-adressing strategies for pharmaceuticals.